Business Description
Coca-Cola FEMSA, S.A.B. de C.V., a franchise bottler, produces, markets, sells, and distributes Coca-Cola trademark beverages. The company offers sparkling beverages, including colas and flavored sparkling beverages; and waters and other beverages, such as juice drinks, coffee, teas, milk, value-added dairy products, sports and energy drinks, and plant-based drinks. It provides a portfolio of products through retail outlets, such as wholesale supermarkets, discount stores, and convenience stores; retailers, such as restaurants and bars, as well as stadiums, auditoriums, and theaters; points-of-sale outlets; and home delivery, supermarkets, and other locations. In addition, the company distributes and sells Heineken beer products in its Brazilian territories. It operates in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Brazil, Argentina, and Uruguay. The company was founded in 1979 and is headquartered in Mexico City, Mexico. Coca-Cola FEMSA, S.A.B. de C.V. is a subsidiary of Fomento Economico Mexicano, S.A.B. de C.V.
Business History
Generated: Jun 7, 2026 5:14pmPrice Overview
Last updated: Jun 7, 2026 5:12pm (19d ago)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 142.00
Total Equity: $146.20B
Shares: 21,008,300
Total Debt: $79.78B
Cash: $28.07B
EBITDA: $56.07B
Total Debt: $79.78B
Cash: $28.07B
Revenue: $291.75B
Revenue: $291.75B
Revenue: $291.75B
Total Equity: $146.20B
Tax Rate: 33.6%
Equity: $146.20B
Total Debt: $79.78B
Cash: $28.07B
Current Liabilities: $66.76B
Long-Term Debt: $71.83B
Total Debt: $79.78B
Total Equity: $146.20B
Shares: 21,008,300
Shares: 21,008,300
CapEx: -$20.32B
Shares: 21,008,300
Stock Price: $106.47
Net Income: $23.85B
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 7, 2026 5:18pm (19d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $194.8B | $226.7B | $245.1B | $279.8B | $291.7B |
| Cost of Revenue | $106.2B | $126.4B | $134.2B | $151.1B | $158.6B |
| Gross Profit | $88.6B | $100.3B | $110.9B | $128.7B | $133.2B |
| Operating Expenses | $61.1B | $69.7B | $76.5B | $89.0B | $92.6B |
| Operating Income | $27.5B | $30.6B | $34.3B | $39.7B | $40.6B |
| Net Income | $15.7B | $19.0B | $19.5B | $23.7B | $23.8B |
| EBITDA | $37.3B | $40.4B | $43.8B | $52.8B | $56.1B |
| EPS | $74.80 | $90.60 | $93.00 | $113.00 | $142.00 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 7, 2026 5:12pm (19d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $47.2B | $40.3B | $31.1B | $32.8B | $28.1B |
| Total Current Assets | $80.4B | $79.2B | $67.7B | $75.1B | $74.6B |
| Total Assets | $271.6B | $278.0B | $273.5B | $308.0B | $314.5B |
| Current Liabilities | $46.2B | $58.0B | $54.9B | $67.2B | $66.8B |
| Long-Term Debt | $83.3B | $70.1B | $66.7B | $71.9B | $71.8B |
| Total Liabilities | $144.0B | $146.1B | $139.8B | $157.4B | $160.5B |
| Total Equity | $121.6B | $125.4B | $127.0B | $143.4B | $146.2B |
| Retained Earnings | $81.0B | $88.7B | $96.0B | $107.0B | $115.5B |
Cash Flow (Annual)
Last updated: Jun 7, 2026 5:18pm (19d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $32.7B | $35.5B | $42.3B | $42.4B | $26.0B |
| Capital Expenditure | -$10.0B | -$17.7B | -$20.6B | -$25.8B | -$20.3B |
| Free Cash Flow | $22.7B | $17.8B | $21.7B | $16.7B | $5.7B |
| Acquisitions (net) | $0 | -$2.4B | -$1.3B | -$751.0M | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $3.8B | -$7.0B | -$9.2B | $1.7B | -$579.9M |
Analyst Estimates (Annual)
Last updated: Jun 7, 2026 5:12pm (19d ago)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$342.4B $332.6B – $352.1B
|
$365.6B $356.6B – $376.9B
|
$402.0B $392.1B – $414.5B
|
$433.5B $422.8B – $447.0B
|
| EBITDA |
$67.8B $65.8B – $69.7B
|
$72.4B $70.6B – $74.6B
|
$79.6B $77.6B – $82.0B
|
$85.8B $83.7B – $88.5B
|
| Net Income |
$2.9B $2.7B – $3.1B
|
$3.2B $3.0B – $3.5B
|
$3.6B $3.5B – $3.7B
|
$3.9B $3.8B – $4.1B
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 7, 2026 5:18pm (19d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +16.4% | +8.1% | +14.2% | +4.3% |
| Gross Profit Growth | +13.2% | +10.5% | +16.1% | +3.4% |
| Operating Income Growth | +11.5% | +12.1% | +15.7% | +2.2% |
| Net Income Growth | +21.2% | +2.6% | +21.5% | +0.5% |
| EBITDA Growth | +8.3% | +8.3% | +20.6% | +6.1% |
Insider Trading (Recent)
Last updated: Jun 7, 2026 5:17pm (19d ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-05-27 | Cutrale Jose Luis | 0.00 | $0.00 | $0 | |
| 2026-05-22 | Nicolau Gutierrez Luis Alfonso | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Kim LeRoy | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Cutrale Jose Henrique | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Harris Mark D | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Lopes Amaral Westin Pereira Camila | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Craig Ian M. | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Craig Ian M. | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Reuben Hatounian Catherine Nicole | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Reuben Hatounian Catherine Nicole | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Coindreau Montemayor Gabriel | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Diaz-Caneja Guillen Antonio | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Diaz-Caneja Guillen Antonio | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Pereyra Mendez Eduardo | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Fernandes Vieira de Oliveira Thiago | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Ponce Garcia Washington Fabricio | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Ponce Garcia Washington Fabricio | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Bertelloni Nicolas | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Ocejo Zubizarreta Aitor | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Fernandez Carbajal Jose Antonio | 0.00 | $0.00 | $0 |
Dividend History (Last 20)
Last updated: Jun 7, 2026 5:12pm (19d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-04-20 | $1.12 | 2026-04-07 | 2026-04-20 | 2026-05-01 |
| 2025-12-08 | $1.01 | 2025-11-25 | 2025-12-08 | 2025-12-19 |
| 2025-10-14 | $1.00 | 2025-10-03 | 2025-10-14 | 2025-10-27 |
| 2025-07-15 | $0.98 | 2025-07-07 | 2025-07-15 | 2025-07-28 |
| 2025-04-22 | $0.94 | 2025-04-09 | 2025-04-22 | 2025-05-05 |
| 2024-12-06 | $0.69 | 2024-11-21 | 2024-12-06 | 2024-12-19 |
| 2024-10-11 | $0.78 | 2024-10-02 | 2024-10-14 | 2024-10-25 |
| 2024-07-15 | $0.83 | 2024-07-02 | 2024-07-15 | 2024-07-26 |
| 2024-04-12 | $0.92 | 2024-04-03 | 2024-04-15 | 2024-04-26 |
| 2023-10-31 | $1.59 | 2023-10-18 | 2023-11-01 | 2023-11-13 |
| 2023-05-01 | $1.60 | 2023-04-18 | 2023-05-02 | 2023-05-15 |
| 2022-10-31 | $1.25 | 2022-10-21 | 2022-11-01 | 2022-11-14 |
| 2022-04-29 | $1.32 | 2022-04-19 | 2022-05-02 | 2022-05-13 |
| 2021-10-29 | $1.21 | 2021-10-19 | 2021-11-01 | 2021-11-15 |
| 2021-04-30 | $1.24 | 2021-04-20 | 2021-05-03 | 2021-05-14 |
| 2020-10-29 | $1.13 | 2020-10-16 | 2020-10-30 | 2020-11-13 |
| 2020-05-01 | $1.00 | 2020-04-21 | 2020-05-04 | 2020-05-15 |
| 2019-10-30 | $0.89 | 2019-10-03 | 2019-10-31 | 2019-11-12 |
| 2019-05-03 | $0.93 | 2019-05-06 | 2019-05-15 | |
| 2018-10-30 | $0.83 | 2018-10-19 | 2018-10-31 | 2018-11-13 |
Narrative Economics
market-narrative step).
Delvantic AI Findings
The raw numbers tell a coherent story that the synthesis layer mangled badly. KOF posts MXN-denominated financials: 2025 annual revenue MXN 291.75B, NI MXN 23.85B, OCF MXN 26.04B. The market cap of $22.37B is USD. The "composite fair value $9,974" output is a unit-mismatch artifact — somebody DCF'd peso cash flows and compared to a dollar share price. Ignore it entirely. The P/B of 0.245 and P/S of 0.123 are the same artifact (peso book/sales vs dollar price per ADR which represents 10 local shares). The honest read: TTM P/E ~16.9x, ~4.1% dividend yield, EV/EBITDA in the high single digits once you fix the units — that is a normal, slightly cheap, EM bottler multiple, not a screaming bargain.
On the operating trajectory: annual revenue grew 17% (2022), 8.1% (2023), 14.2% (2024), 4.3% (2025) — clear deceleration, and the deceleration is consistent with what FEMSA has actually disclosed (Mexico volume softness, Argentina translation, weather). Operating margin held at ~13.9% and net margin at ~8.2% — no real margin compression once you net out FX, contradicting Market Forces' "inflation-masked margin compression" claim. Quarterly NI bounces between MXN 5.1–5.9B with a Q4 2024 outlier of MXN 7.28B; the Q4 2025 figure of $4.25B revenue / $409.8M NI is almost certainly a data row in USD while neighbors are in MXN — another unit problem the models swallowed. The FCF "CAGR -48.6%" is the one number worth taking seriously: FCF MXN 5.72B on OCF MXN 26.04B implies capex MXN 20.3B, ~7% of sales, which is elevated vs the historical 5-6%. That's the real bear case — capex intensity is consuming the cash that funds the dividend. Whether that's a structural reinvestment cycle (digital, cooler placement, Brazil capacity) or permanent FCF impairment is the actual debate.
The prior models are mostly useless here. Valuation Synthesis is broken (units). Market Forces invents "collapsing cash generation" and "dangerous EM leverage" with no leverage data shown — the balance sheet line is blank, so that's a hallucination. Thesis Evaluation cites "P/E of 0.7x" which is obviously the P/B artifact misread. The Narrative layer is the only output that actually engages with KOF as it exists: largest Coca-Cola bottler by volume, structural moat in Mexico/Brazil, anchored to fundamentals, durable franchise. The Pre-Flight thesis is also directionally right — market is pricing modest growth plus an EM risk premium, fair enough. The contrarian case worth airing: KOF's Mexico business is ~60% of volume and Mexico is staring at USMCA renegotiation risk, peso volatility, and a sugar-tax regime that keeps tightening; Brazil is competitive vs Ambev; and the capex step-up may not normalize if Coca-Cola Co. is pushing bottlers to fund more of the system's growth investment. A 4% yield with mid-single-digit organic growth and rising capex is not obviously cheap — it's appropriately priced.
Where I land: KOF at $106 on ~16.9x earnings, 4.1% yield, mid-single-digit revenue growth, stable mid-teens operating margins, and a fortress franchise position is a fair-value-to-slightly-cheap mature EM compounder — not the 100x undervalued absurdity the synthesis produced, and not the deteriorating disaster Market Forces described. The real risk is the capex/FCF compression: if 2026 FCF doesn't recover toward MXN 12-15B range, the dividend coverage thesis weakens and the multiple should compress. If it does recover, $115-125 is reasonable. I dissent from the synthesis "undervalued by 10,000%" verdict (unit error), dissent from Market Forces' "deteriorating quality" framing (unsupported), and partially agree with the Narrative layer's "anchored steady compounder" read. Insider data is unusable (all zero-share entries with no names). The balance sheet blanks are a real gap — without total debt I can't confirm the leverage profile, though KOF historically runs ~1.5-2
GPT Critique
Upon reviewing the raw data for Coca-Cola FEMSA, I'm struck by the company's robust revenue growth over the past few years, albeit with a notable deceleration from 14.2% in 2024 to 4.3% in 2025. The annual revenue of MXN 291.75B for 2025, with a net income of MXN 23.85B, suggests a relatively stable earnings profile, despite the recent deceleration. The quarterly financials indicate minor fluctuations, with Q4 2025 revenue and net income figures likely reflecting a currency mismatch, as Opus noted. The operating cash flow of MXN 26.04B and capex of MXN 20.32B result in a free cash flow of MXN 5.72B, highlighting a significant capex intensity that could constrain future dividend payouts. This aligns with the FCF decline of 48.6%, suggesting potential stress on cash generation capabilities.
I concur with Opus's dismissal of the flawed valuation synthesis, recognizing the unit mismatch between peso-denominated financials and dollar-denominated market cap. This artifact led to an erroneous undervaluation claim, which should be disregarded. Opus correctly identifies the company's TTM P/E of 16.9x and a 4.1% dividend yield, indicating a more conventional valuation for an emerging market bottler. I also agree with his refutation of the Market Forces' characterization of "collapsing cash generation" and "dangerous EM leverage," given the absence of leverage data and the relatively stable operating and net margins of around 13.9% and 8.2%, respectively.
However, I diverge from Opus's partial alignment with the narrative layer's "anchored steady compounder" depiction. While the fundamentals suggest stability, the increasing capex and decelerating revenue growth signal potential headwinds that could challenge the company's ability to maintain its dividend yield and growth trajectory. The narrative's minimal intensity may underestimate these risks, especially in light of potential macroeconomic instabilities in Latin America, including currency volatility and regulatory challenges in key markets like Mexico and Brazil.
A careful skeptic might argue that both my and Opus's analyses understate the risks associated with the company's capex-driven free cash flow compression and the broader geopolitical and economic uncertainties in its operating regions. They might also question the sustainability of current margin levels in the face of potential shifts in consumer preferences and competitive pressures.